Real-world data in the era of immune checkpoint inhibitors

被引：0
|
作者：
Narita, Yukiya [1 ]
机构：
[1] Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.05.428
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SY5-5
引用
收藏
页码：S250 / S250
页数：1
相关论文
共 50 条
  • [41] Immune checkpoint inhibitors in patients with solid tumors and poor performance status A prospective data from the real-world settings
    Kapoor, Akhil
    Noronha, Vanita
    Patil, Vijay M.
    Menon, Nandini
    Joshi, Amit
    Abraham, George
    Prabhash, Kumar
    MEDICINE, 2021, 100 (13) : E25115
  • [42] Concomitant use of antibiotics and immune checkpoint inhibitors in patients with solid neoplasms: retrospective data from real-world settings
    Kapoor, Akhil
    Noronha, Vanita
    Patil, Vijay M.
    Joshi, Amit
    Menon, Nandini
    Mahajan, Abhishek
    Janu, Amit
    Prabhash, Kumar
    ECANCERMEDICALSCIENCE, 2020, 14
  • [43] Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data
    Ruggiero, Rosanna
    Stelitano, Barbara
    Fraenza, Federica
    di Mauro, Gabriella
    Scavone, Cristina
    Sportiello, Liberata
    Rafaniello, Concetta
    Di Napoli, Raffaella
    Danesi, Romano
    Del Re, Marzia
    Rossi, Francesco
    Capuano, Annalisa
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [44] Real-world evidence of incidence and outcomes of aplastic anaemia following administration of immune checkpoint inhibitors
    Dasari, Srilatha
    Tse, William
    Wang, Jiasheng
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 202 (06) : 1205 - 1208
  • [45] Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis
    Tsai, Hong-Ming
    Han, Meng-Zhi
    Lin, Yih-Jyh
    Chang, Ting-Tsung
    Chen, Chiung-Yu
    Cheng, Pin-Nan
    Chuang, Chiao-Hsiung
    Wu, I-Chin
    Chen, Po-Jun
    Kang, Jui-Wen
    Chiu, Yen-Cheng
    Chiu, Hung-Chih
    Chien, Shih-Chieh
    Kuo, Hsin-Yu
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (07) : 1929 - 1937
  • [46] Hyperprogressive Disease (HPD) in Solid Tumours Receiving Immune Checkpoint Inhibitors in a Real-World Setting
    Kanjanapan, Yada
    Guduguntla, Geetha
    Varikara, Ashwati Krishnan
    Szajer, Jeremy
    Yip, Desmond
    Cockburn, John
    Fadia, Mitali
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22
  • [47] A real-world study of immune checkpoint inhibitors in advanced triple-negative breast cancer
    Zhao, Weihong
    Zhang, Zheng
    Zhang, Yadi
    Chen, Yimeng
    Zhu, Yimin
    Liu, Chuanling
    Shao, Jiakang
    Zhang, Li
    Liu, Mei
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [48] Acute kidney injury in patients receiving immune checkpoint inhibitors: a retrospective real-world study
    Lumlertgul, Nuttha
    Vassallo, Pietro
    Tydeman, Florence
    Lewis, Natasha
    Hobill, Abigail
    Weerapolchai, Kittisak
    Nordin, Nurul Zaynah
    Seylanova, Nina
    Martin, Luke
    Cennamo, Armando
    Wang, Yanzhong
    Rigg, Anne
    Shaunak, Nisha
    Ostermann, Marlies
    EUROPEAN JOURNAL OF CANCER, 2023, 191
  • [49] Immune checkpoint inhibitors increase the risk of kidney transplant rejection: a real-world pharmacovigilance study
    Wu, Junyan
    Huang, Jianxiang
    Zhu, Jianhong
    He, Zhichao
    Chen, Mengting
    Gao, Siyuan
    Liang, Dan
    Yu, Xiaoxia
    Lu, Chengyu
    EXPERT OPINION ON DRUG SAFETY, 2023, 22 (03) : 231 - 235
  • [50] Real-world experience and outcomes of immune-checkpoint inhibitors (ICI) in hepatocellular carcinoma (HCC)
    Paul, Samuel
    Min, Eric
    Benson, Katherine K.
    Xu, Menglin
    Noonan, Anne M.
    Mittra, Arjun
    Malalur, Pannaga G.
    Roychowdhury, Sameek
    Jin, Ning
    Hays, John L.
    Elkhatib, Rifat T.
    Rahman, Shafia
    Miller, Eric David
    Pardo, Dayssy Alexandra Diaz
    Manne, Ashish
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345